Abacavir is a medication used to treat HIV infection. It works by stopping the virus from copying itself in the body. It's taken as a pill, usually once a day. It's important for people with HIV to take their medication exactly as prescribed by their doctor.
Every report comes from a Lived member, sent anonymously.
Have you tried Abacavir for HIV Infection?
Abacavir is a prescription medicine for HIV (human immunodeficiency virus) infection, approved for adults and for children 3 months and older. It is sold on its own as Ziagen and as generic tablets and liquid, and it is also one of three ingredients in Triumeq, a single daily tablet that combines abacavir with two other HIV medicines, dolutegravir and lamivudine. A two-drug abacavir and lamivudine tablet, formerly sold as Epzicom, is now available as a generic. Abacavir is never used by itself. HIV treatment always combines several medicines, because the virus quickly becomes resistant to any single drug. Abacavir does not cure HIV, but as part of a full regimen it helps keep the virus under control and lets the immune system recover.
HIV copies itself inside immune cells by turning its genetic material into DNA, using an enzyme called reverse transcriptase. Abacavir belongs to a group of HIV medicines called nucleoside reverse transcriptase inhibitors, or NRTIs. Inside the body it is converted into a look-alike of one of the building blocks of DNA. When the virus picks up this false building block, the DNA chain it is making cannot be completed, so the virus produces far fewer new copies. With less virus in the blood (the viral load), the immune system can rebuild its CD4 cells, the white blood cells HIV destroys. That recovery is what lowers the risk of serious infections and other HIV-related illness over time.
Before anyone starts abacavir, a blood test checks for a gene variant called HLA-B*5701. People who carry it have a much higher risk of a serious allergic reaction to abacavir and should not take it. The test only needs to be done once if the result is documented. Adults usually take abacavir once or twice a day, with or without food, together with their other HIV medicines. Children's doses are based on weight, and a liquid form is available for those who cannot swallow tablets. People with mild liver problems take a lower dose of the liquid. If a dose is missed, take it when you remember, but do not double up. Taking every dose and not running out matters. Gaps in treatment let the virus multiply and can make it resistant to medicines. A break also has a specific risk with abacavir: restarting after stopping, even for a few days, has rarely triggered a severe reaction in people who never reacted before. Talk with the prescriber before restarting, and restart only where medical help is close at hand.
Nausea, headache, tiredness, a general unwell feeling and vivid dreams or trouble sleeping are among the more common side effects. They are often mild, and they are worth mentioning if they persist. The most important risk is a hypersensitivity reaction, an allergic-type reaction that can affect many organs and can be fatal if abacavir is continued. It most often starts within the first six weeks (half of reactions begin within about nine days), though it can happen later. Testing for HLA-B*5701 has made it much less common, but people without the gene variant can still have one. The warning signs fall into five groups: fever; rash; nausea, vomiting, diarrhea or stomach pain; feeling generally ill, very tired or achy; and shortness of breath, cough or sore throat. If you have symptoms from two or more of these groups, call your prescriber right away to find out whether to stop. Because the signs can look like flu or a stomach bug, keep the warning card the pharmacy provides with you. A rare but serious problem shared by medicines in this group is lactic acidosis, a buildup of acid in the blood, which can come with an enlarged, fatty liver. Unusual muscle pain, trouble breathing, stomach pain with nausea and vomiting, or marked weakness should be reported promptly.
Anyone who has had a hypersensitivity reaction to abacavir must never take it again, in any form. That includes Ziagen, Triumeq and generic combination tablets. A second exposure can cause a more severe reaction, including a dangerous drop in blood pressure, within hours. Dispose of any leftover tablets after a reaction. Abacavir is not used in people with moderate or severe liver disease. Some observational studies have linked it with a higher risk of heart attack, while pooled clinical trials have not, so the link remains uncertain. Prescribers weigh existing heart risk, such as high blood pressure, high cholesterol, diabetes or smoking, when choosing it, and it helps to address those risks either way. For combination tablets that also contain lamivudine, such as Triumeq, everyone is tested for hepatitis B first. In people who have both HIV and hepatitis B, stopping lamivudine can cause a severe hepatitis flare, so these medicines should not be stopped without a plan. Few drugs interact with abacavir itself. People on methadone maintenance occasionally need a higher methadone dose, and riociguat (a medicine for high blood pressure in the lungs) may need a lower dose. Alcohol slows the body's clearance of abacavir, so it is worth discussing how much you drink. The US label advises people with HIV not to breastfeed.
Abacavir is part of a long-term regimen. With consistent use, the full combination usually brings HIV in the blood down over weeks to months, and regular blood tests track the viral load and CD4 count to confirm it is working. The first six weeks deserve particular attention because that is when hypersensitivity reactions usually appear. After that, most people settle into a routine with few noticeable effects. As the immune system recovers, some people develop inflammation from an infection that was already present, a response called immune reconstitution syndrome. New signs of infection after starting treatment should be reported promptly. Treatment continues even when you feel well and tests look good, because stopping lets the virus return. Any change in the regimen, including a pause, is best planned with the prescriber, since restarting abacavir carries its own precautions.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Abacavir, what you've noticed, or ask the community a question.